Evaluation of 1,5-Anhydroglucitol As a Biomarker for Type 2 Diabetes Mellitus in Patients Without Overt Nephropathy. Braz. J. Pharm. Sci. 2022, 57. https://doi.org/10.1590/s2175-97902020000419078.